Key takeaways:
- Zimmer Biomet reported its first-quarter 2024 financial results.
- The company reported $1.889 billion in net sales and $172.4 million in net earnings for the first quarter of 2024.
Zimmer Biomet Holdings Inc. announced increased net sales in its first-quarter 2024 financial results, according to a company press release.
Zimmer Biomet reported $1.889 billion in net sales, a 3.2% increase from the prior year period and a 4.4% increase on a constant currency basis. The company reported $172.4 million in net earnings and $399.7 million in adjusted net earnings for the first quarter of 2024. The company also reported a diluted earnings per share of $0.84 for the quarter.
“We are pleased with the execution, progress and strong performance the team delivered in the first quarter,” Ivan Tornos, president and CEO of Zimmer Biomet, said in the release. “As we move forward, we are focused on continuing this momentum and delivering on our key priorities to advance people and culture, achieve operational excellence and drive innovation and diversification – all with the goal of delivering on our mission.”